Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV

Publish date: February 9, 2021

AETC source: Northeast/Caribbean AETC, Mountain West AETC, AETC National Coordinating Resource Center

Session 4 of the AETC Program HIV and SARS-CoV-2 Winter Webinar Series (recorded 1/27/21). Presenters discussed the clinical impact of HIV infection and COVID-19, analyzed the latest data on clinical presentation and clinical outcomes of people with HIV who develop COVID-19, and reviewed treatment strategies for COVID-19 (including antiretroviral drugs) for people with HIV.

Speakers

Steven Johnson, MD, Professor of Medicine and Associate Division Head for Clinical Affairs, Division of Infectious Diseases, University of Colorado School of Medicine, NIH Advisory Committee Member

Roy Gulick, MD, MPH, Rochelle Belfer Professor in Medicine, Chief, Division of Infectious Diseases, Weill Cornell Medicine, NIH Advisory Committee Member

View more sessions in this webinar series